Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2025-12-25 @ 5:11 AM
NCT ID:
NCT01675427
Eligibility Criteria:
Inclusion Criteria:
* Adult (according to local legislation) male or female patient
* Chronic hepatitis C (CHC)
* Patients naïve to CHC treatment or patients who received prior interferon-based therapy for CHC for whom data on treatment received and treatment outcome is available; information on fibrosis stage prior to previous treatment is also required
Exclusion Criteria:
* Co-infection with hepatitis B
* History or evidence of decompensated liver disease
* History of major organ transplantation with an existing functional graft (including liver transplantation)
* End stage renal disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01675427
Study Brief:
Protocol Section:
NCT01675427